10128-73-1 Usage
Description
4-Pyridinecarboxamide,3-hydroxy-(9CI), also known as 3-Hydroxyisonicotinamide, is an organic compound with the molecular formula C6H6N2O2. It belongs to the pyridine carboxamide family and features a hydroxyl group at the 3rd position. 4-Pyridinecarboxamide,3-hydroxy-(9CI) is characterized by its potential reactivity and applicability in various chemical and pharmaceutical processes.
Uses
Used in Pharmaceutical Industry:
4-Pyridinecarboxamide,3-hydroxy-(9CI) is used as a reactant in the synthesis of furopyridine derivatives, which are known as FXa inhibitors. FXa inhibitors are a class of anticoagulant drugs that target factor Xa, a key enzyme in the coagulation cascade. These inhibitors play a crucial role in the prevention and treatment of various thrombotic disorders, such as deep vein thrombosis, pulmonary embolism, and acute coronary syndrome.
In the synthesis of furopyridine derivatives, 4-Pyridinecarboxamide,3-hydroxy-(9CI) serves as a key building block, contributing to the development of novel and effective FXa inhibitors with improved pharmacological properties. The compound's reactivity and structural features make it a valuable component in the design and synthesis of these therapeutic agents, ultimately contributing to advancements in the treatment of thrombotic conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 10128-73-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,1,2 and 8 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 10128-73:
(7*1)+(6*0)+(5*1)+(4*2)+(3*8)+(2*7)+(1*3)=61
61 % 10 = 1
So 10128-73-1 is a valid CAS Registry Number.
10128-73-1Relevant articles and documents
Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias
-
Paragraph 0130; 0131; 0132; 0133; 0134, (2016/02/12)
The invention relates to iron(III) complex compounds and pharmaceutical compositions comprising them for the use as medicaments, in particular for the treatment and/or prophylaxis of iron deficiency symptoms and iron deficiency anemias.
